INTERCEPT PHARMACEUTICALS, INC.·4

Sep 16, 4:02 PM ET

Berrey M Michelle 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Sep 16, 2022

Insider Transaction Report

Form 4
Period: 2022-09-14
Berrey M Michelle
President, R&D and CMO
Transactions
  • Tax Payment

    Common Stock

    2022-09-14$17.14/sh1,246$21,35671,188 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

Documents

1 file
  • 4
    tm2225991-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT